...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Orphan Disease Announcement

I don't know the timing.

Regarding the FDA this is where it goes beyond my knowledge. For the PNH orphan indication RVX is using the RVX-208 molecule which is also being used in the BOM trial. I do not understand the regulatory considerations when trials are being conducted with the same drug but for different indications.

Share
New Message
Please login to post a reply